Affiliation:
1. Industry‐Academia Cooperation Foundation Hongik University Sejong‐si South Korea
2. Department of Chemical Engineering and Applied Chemistry Chungnam National University Daejeon South Korea
3. Department of Biological and Chemical Engineering Hongik University Sejong‐si South Korea
Abstract
AbstractProgrammed cell death‐ligand 1 (PDL1) is a transmembrane protein that is characterized as an immune regulatory molecule. We recently developed a recombinant single‐chain fragment of variable domain (scFv) against PDL1, which showed high binding efficiency to purified recombinant PDL1 protein. However, at that time, proof‐of‐concept data for the effect of scFv using PDL1‐expressing cells was lacking. In this study, we conducted two kinds of cell‐based immunoassays, western blotting and enzyme‐linked immunosorbent assay, using anti‐PDL1 scFv. The results indicate that scFv can selectively and sensitively detect PDL1 from PDL1 positive human cancer cell lines. Our findings suggest that scFv could be used as a potential PDL1 inhibitor agent and probe for cell‐based immunoassays to detect PDL1.
Funder
National Research Foundation of Korea
Hongik University